Adalimumab impact on fatigue measured by FACIT-F: a study of rheumatoid arthritis patients in Saudi Arabia

Figures & data

Table 1 Patient therapy type prior to enrollment

Type of therapy	Frequency	Percent
No therapy	1	1.7
Steroid alone	5	8.5
Steroid + MTX	12	20.3
Steroid + DMARD	4	6.8
MTX alone	13	22
MTX + DMARD	20	33.9
DMARD alone	4	6.8

Abbreviations: MTX, methotrexate; DMARD, disease-modifying antirheumatic drug.

Table 2 Demographic information

Variables	Categories
Sex	Male 6 (10.2%)						Female 53 (89.8%)
Presence of EAM	Yes 2 (3.4%)						No 57 (96.6%)
Marital status	Single 5 (8.5%)				Married 51 (86.4%)					Divorced 3 (5.1%)
Ethnicity	Arab 53 (89.8%)				Caucasian 4 (6.8%)					Asian 2 (3.4%)
Education level	<Secondary 11 (18.6%)		Secondary 21 (35.6%)				University 26 (44.1%)				>University 1 (1.7%)
Occupation	House wife 40 (67.8%)	Student 3 (5.1%)		Teacher 5 (0.5%)		Labor work 4 (6.8%)		Clerk 2 (3.4%)	Unemployed 3 (5.1%)			Others 2 (3.4%)
	Mean ± SD						95% CI for mean
Age (years)	45.25±11.82						33.43–57.07
Height (cm)	160.36±12.65						147.71–173.01
Weight (kg)	77.10±19.24						57.86–96.34

Abbreviations: EAM, extra-articular manifestations; CI, confidence interval.